A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides.
There is now extensive evidence that synthetic peptides corresponding to linear sequences of MHC molecules are effective immunoregulators, targeting the immune response at many different sites. It has been previously shown that peptides derived from a highly conserved region of MHC class II inhibit proliferation to autoantigen and to both the direct and indirect pathways of allorecognition. This study demonstrates that inhibition of lymphocyte proliferation by nonpolymorphic MHC class II peptides, specifically HLA-DQA1, is sequence-specific and that the inhibitory effect is mediated through the induction of apoptosis in antigen-presenting cells via a caspase-independent mechanism. In addition, T lymphocytes stimulated in the presence of HLA-DQA1 are rendered hyporesponsive to subsequent stimuli. Immunomodulation by HLA-DQA1 is effective in vivo because it prevents both the priming and the effector function of primed allogeneic T cells in a murine DTH model. These observations have important implications for the development of a novel therapy for immune-mediated diseases.
Murphy
Barbara
B
Renal Division, Mount Sinai School of Medicine, New York, New York 10029, USA. Barbara.Murphy@mssm.edu
Yu
Joyce
J
Jiao
Qingsheng
Q
Lin
Marvin
M
Chitnis
Tanuja
T
Sayegh
Mohamed H
MH
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D017209:Apoptosis; D005802:Genes, MHC Class II / Q000235:genetics / Q000276:immunology*; D006683:HLA-DQ Antigens / Q000235:genetics / Q000276:immunology*; D059848:HLA-DQ alpha-Chains; D008297:Male; D051379:Mice; D013601:T-Lymphocytes / Q000276:immunology* / Q000502:physiology
D000276:Adjuvants, Immunologic; D006683:HLA-DQ Antigens; D059848:HLA-DQ alpha-Chains; C069050:HLA-DQA1 antigen